Head of Baqiyatallah University of Medical Sciences

Tehran (IP) - Head of Baqiyatallah University of Medical Sciences said the medicine produced for Covid-19 patients in this university has received clinical trial authorization from the Food and Drug Organization of Iran to begin clinical studies.

Iran PressIran news: On March 1, Brigadier General Alireza Jalali, Head of IRGC's Baqiyatallah University of Medical Sciences Speaking at the Press conference to discuss the latest developments on Coronavirus outbreak broadcasted live by Iran Press News Agency said that discovery of coronavirus' medicine has begun … even one of the drugs has been effective at the lab level and it will be tested soon.

In a relevant development, Mostafa Qanei, Secretary of Biotechnology Development Headquarters of the Vice Presidency for Science and Technology, said two knowledge-based projects in the field of Coronavirus test Kit will soon reach the mass production stage and they will enter their productions to the market.

However, these plans must first be approved by the Food and Drug Organization of the Ministry of Health and Medical Education, and then companies must mass-produce the kits within a week.

205

Read More:

IRGC top health official: COVID-19 under Iranian physicians close watch

WHO envoy praises Iran over fighting with Coronavirus, impressed by healthcare services

Iranian cities disinfected efficiently countering Coronavirus